Medication info
Taeguk Simvastatin Tablets

Taeguk Simvastatin Tablets

Prescription medicationTabletOral
Ingredient · strength
Simvastatin›20mg / 1 tablet
Manufacturer / importer
Taeguk Pharmaceutical Co., Ltd.
Appearance
Yellowish-brown oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200401145 · Notified 2004.05.03 · Insurance code 644802220

Summary

Main use
Improvement of hyperlipidemia, improvement of familial hypercholesterolemia in children, and prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended starting dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. The recommended dose is 5 ~ 40 mg of this medicine once daily in the evening. Adjust the dose as appropriate based on the initial LDL cholesterol level before starting treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if cholesterol levels fall below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of this medicine at a dose of 80 mg, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) Refer to the information below for recommended doses in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia Results from controlled clinical trials indicate that patients with homozygous familial hypercholesterolemia should receive 40 mg of this medicine once daily in the evening. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In elderly patients, a maximum reduction in cholesterol levels can be achieved with a daily dose of 20 mg of this medicine. (3) Administration to patients receiving verapamil, diltiazem, or dronedarone When this medicine is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg daily. (4) Administration to patients receiving amiodarone, amlodipine, or ranolazine When this medicine is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg daily. (5) Coadministration with other lipid-lowering agents This medicine is effective when administered alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see 2. Patients in whom the medicine must not be administered under Precautions for Use) and fenofibrate), the dose of this medicine must not exceed 10 mg daily. (6) Administration to patients with renal impairment Because this medicine is not extensively excreted by the kidneys, dose adjustment is not required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg daily and monitor carefully.
Child dose
Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.

Ingredients

Manufacturer
Taeguk Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia, improvement of familial hypercholesterolemia in children, and prevention of cardiovascular disease

  • Coronary heart disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • other cerebrovascular diseases
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • hypertriglyceridemia
  • familial hypercholesterolemia
  • early risk factors for cardiovascular disease
View approved original text

This medication helps reduce the risk of cardiovascular diseases. It particularly lowers the risk of death from heart disease and the likelihood of myocardial infarction and stroke in individuals with a history of coronary heart disease, diabetes, peripheral vascular disease, and stroke. Additionally, it reduces the risks associated with other vascular surgeries. It is also used in the treatment of hyperlipidemia, improving blood lipid levels by decreasing total cholesterol, LDL-cholesterol, Apo-B protein, and triglycerides while increasing HDL-cholesterol levels. Specifically, it is used as an adjunct to diet in children with familial hypercholesterolemia to help manage cholesterol levels. Therefore, this medication improves overall cardiovascular health through the prevention of cardiovascular diseases and management of hyperlipidemia.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended starting dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. The recommended dose is 5 ~ 40 mg of this medicine once daily in the evening. Adjust the dose as appropriate based on the initial LDL cholesterol level before starting treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if cholesterol levels fall below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of this medicine at a dose of 80 mg, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) Refer to the information below for recommended doses in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia Results from controlled clinical trials indicate that patients with homozygous familial hypercholesterolemia should receive 40 mg of this medicine once daily in the evening. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In elderly patients, a maximum reduction in cholesterol levels can be achieved with a daily dose of 20 mg of this medicine. (3) Administration to patients receiving verapamil, diltiazem, or dronedarone When this medicine is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg daily. (4) Administration to patients receiving amiodarone, amlodipine, or ranolazine When this medicine is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg daily. (5) Coadministration with other lipid-lowering agents This medicine is effective when administered alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see 2. Patients in whom the medicine must not be administered under Precautions for Use) and fenofibrate), the dose of this medicine must not exceed 10 mg daily. (6) Administration to patients with renal impairment Because this medicine is not extensively excreted by the kidneys, dose adjustment is not required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg daily and monitor carefully.

Child dose

Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.

Precautions

This medication is primarily used to lower blood cholesterol levels. However, caution is required as muscle abnormalities may occur while taking this medication. Particularly, co-administration with certain drugs or high doses may significantly increase the risk of serious muscle damage such as myopathy or rhabdomyolysis. Symptoms like muscle pain or weakness should be reported to a physician immediately, and medication should be discontinued if necessary. Individuals with liver function problems or liver disease should not take this medication and should have regular liver function tests. Pregnant women or those who may become pregnant, as well as nursing mothers, should not take this medication and must consult a physician if planning to become pregnant. This medication may interact with various drugs, so patients taking other medications must inform their physician or pharmacist. Specifically, co-administration with certain antifungal agents, antibiotics, immunosuppressants, calcium channel blockers, and some lipid-lowering agents may increase the risk of side effects. Elderly patients, those with kidney or thyroid issues, or those who consume alcohol regularly should use this medication with extra caution. It is only used in pediatric patients aged 10 years and older who meet specific conditions, and its effects on growth and sexual maturation will be evaluated by a doctor. While taking this medication, symptoms such as muscle pain, liver function abnormalities, neurological symptoms, and allergic reactions may present; any symptoms should be consulted with healthcare professionals immediately. In the event of an overdose, general emergency measures should be taken, and medication use should always follow a physician's instructions. Lastly, this medication should be stored out of reach of children and kept in its original container, and consumption with specific foods such as grapefruit juice should be avoided.

Side effects

  • Myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • dyspepsia
  • bloating
  • nausea
  • headache
Show 86 more
  • upper respiratory tract infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • sinusitis
  • eczema
  • urinary tract infection
  • muscle cramps
  • arthralgia
  • taste disturbance
  • oculomotor dysfunction
  • facial paresis
  • tremor
  • sensory disturbance
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorder
  • anxiety
  • sleep disorder
  • nightmares
  • depression
  • cognitive impairment
  • severe myasthenia gravis
  • ocular myasthenia
  • hepatitis
  • liver dysfunction
  • jaundice
  • alopecia
  • pruritus
  • skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • cataract progression
  • eye muscle paralysis
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated γ-GTP
  • increased bilirubin level
  • thyroid dysfunction
  • elevated serum creatine kinase
  • interstitial lung disease
  • anaphylaxis
  • angioedema
  • lupus erythematosus-like syndrome
  • rheumatic polymyalgia
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • toxic epidermal necrolysis
  • mucous membrane syndrome
  • pancreatitis
  • liver failure
  • cholestatic jaundice
  • fatty change in the liver
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • anorexia
  • vomiting
  • limb sensory numbness
  • paresthesia
  • cold sensation
  • thrombocytopenia
  • interstitial lung disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that is well-ventilated, at room temperature between 1 degree and 30 degrees Celsius. This will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

Yellowish-brown oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.